Produces and commercializes human milk oligosaccharides (HMOs), notably sialyllactose, via enzymatic large-scale synthesis for infant nutrition, immune support and neurodevelopment applications. Also develops functional oligosaccharides, nucleic-acid and glycosylation-based bio-drugs and gene-therapy materials targeting antiviral, antibacterial and immune-activating uses.